CorFlow Therapeutics AG is based in Baar, Switzerland. It has raised $60M in total funding. Latest round: Series B.
CorFlow Therapeutics AG is based in Baar, Switzerland. CorFlow Therapeutics AG has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for CorFlow Therapeutics AG runs through 2024; nothing later has been disclosed. Investors on record include Broadview Ventures, Panakes Partners, 415 Capital, Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners and 4 others. 10 distinct backers are named across the disclosed rounds.
Every CorFlow Therapeutics AG figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Baar at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026